Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
USA Rare Earth to Host Investor & Analyst Webinar on February 12, 2025
-
United Fire Group, Inc. Announces Its 2024 Fourth Quarter Earnings Call
-
Celestica Announces Fourth Quarter and FY 2024 Financial Results
-
Toll Brothers’ Website to Broadcast Its First Quarter 2025 Earnings Conference Call Live on February 19, 2025 at 8:30 a.m. (ET)
-
Interpublic Schedules Fourth Quarter & Full Year 2024 Earnings Release
-
Brookfield Property Partners Declares Quarterly Dividends on Listed Preferred Units
-
Bassett Reports Fiscal Fourth Quarter Results
-
Parkway International Capital Group Funds $17.5 Million Senior Living Refinance
-
NONPROFIT NEIGHBORS COMBINE EFFORTS TO CARE FOR FLORIDA COMMUNITIES
-
Raymond James Financial Reports Fiscal First Quarter of 2025 Results
-
Clean Power Alliance Achieves $361 Million in Renewable Energy Cost Savings Through Groundbreaking Bond Program Financing
-
Lotus Foods Brings Premium, Gluten-Free, Organic Brown Udon Rice Noodles to Walmart Shelves Nationwide
-
SiriusPoint Announces Dividend on Series B Preference Shares
-
InspireSemi Announces Administrative Update Webinar for Shareholders
-
Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium
-
Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
-
Atlanticus Announces Approval of Quarterly Preferred Stock Dividend
-
Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025
-
Presidio Property Trust Provides Update on Model Home Activity in Q4 2024
-
HCI Group Sets Fourth Quarter and Full Year 2024 Earnings Call for Thursday, February 27, 2025, at 4:45 p.m. ET
-
Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences
-
Matthews International Declares Quarterly Dividend
-
Hawkins, Inc. Reports Third Quarter Fiscal 2025 Results
-
PharmAla Issues Q1 Financial Statements
-
SEALSQ Strengthens its Leadership in Post-Quantum Security by Expanding Its Patent Portfolio
-
GENFIT Announces 2025 Financial Calendar
-
BoC cuts rates amid tariff balancing act: CPA Canada
-
StoneX Group Inc. to Announce 2025 Fiscal First Quarter Earnings on February 5, 2025
-
Landstar System Reports Fourth Quarter Revenue of $1.209B and Earnings Per Share of $1.31
-
California Water Service Group Board of Directors Declares 320th Consecutive Quarterly Dividend and Announces One-Time Special Dividend
-
Brookline Bancorp Announces Fourth Quarter Results
-
Revolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech Conference
-
Soleno Therapeutics to Participate in Upcoming February Investor Conferences
-
Highwoods Declares Quarterly Dividends
-
Oportun to Report Fourth Quarter 2024 Financial Results on Wednesday, February 12, 2025
-
Zevra Therapeutics to Participate at Upcoming Investor Conferences
-
Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference
-
Ethan Allen Reports Fiscal 2025 Second Quarter Results Highlighted by Strong Demand, Margins and Operating Cash Flow
-
Hawkins, Inc. Declares Quarterly Cash Dividend of $0.18 Per Share
-
Robex Announces Sprott Lending as Debt Provider for Kiniero Gold Project
-
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025
-
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
-
Climb Global Solutions Appoints John McCarthy as Chairman of its Board of Directors
-
Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.
-
Silvercrest Asset Management Group Inc. Announces Quarterly Dividend
-
Premium Income Corporation Announces Year End Results
-
Mountain Lake Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Rights Commencing February 3, 2025
-
Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology
-
The Talent Studios Places Ivy City Co. Chief Executive Officer
-
Nokia Corporation: Repurchase of own shares on 29.01.2025
